Ardelyx's (NASDAQ:ARDX) investors will be pleased with their favorable 91% return over the last five years

1d ago, source:

While Ardelyx, Inc. ( NASDAQ:ARDX ) shareholders are probably generally happy, the stock hasn't had particularly ...

Ardelyx, Inc. (ARDX)

5d ago, source: Yahoo Finance

Conference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover ...

Ardelyx gets grant for compound inhibiting enzyme 11-HSD2 for treating hyperkalemia

2d ago, source: Pharmaceutical Technology

Discover how Ardelyx Inc's patented compound inhibits 11-HSD2 enzyme, treating hyperkalemia by stimulating potassium excretion. Learn about the formula, variations, and potential medical applications ...

Ardelyx Stock Collapses After FDA Rejects Its Kidney Disease Candidate Pitch

17d ago, source: AOL

Three months after revealing that the FDA had asked for more information to support tenapanor application for a chronic kidney disease drug, the FDA issued a letter to Ardelyx Inc (NASDAQ ...

Ardelyx, Inc. Reports Employment Inducement Grants

27d ago, source: Business Insider

WALTHAM, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in ...

Ardelyx Inc (ARDX) Stock: Evaluating the Market Performance

16d ago, source: newsheater

To wrap up, the performance of Ardelyx Inc (ARDX) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is ...

Ardelyx, Inc. (41X.F)

1mon ago, source: Yahoo Finance

Ardelyx, Inc. (NASDAQ:ARDX) Q4 2023 Earnings Call Transcript February 22, 2024 Ardelyx, Inc. misses on earnings expectations. Reported EPS is $-0.12 EPS, expectations were $-0.09. Ardelyx, Inc. isn’t ...

Ardelyx Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Ardelyx, Inc. Reports Employment Inducement Grants

28d ago, source: ADVFN

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical ...

Ardelyx Inc

8d ago, source: U.S. News & World Report

Invest with your heart and your phone with as little as $1 with these ESG and socially responsible investing apps.